+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Vasculitis"

From
Vasculitis Market - Product Thumbnail Image

Vasculitis Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Vasculitis Treatment Market - Global Forecast 2025-2032 - Product Thumbnail Image

Vasculitis Treatment Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 191 Pages
  • Global
From
Vasculitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Vasculitis Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 183 Pages
  • Global
From
Immunoglobulin A IgA Vasculitis Global Market Report 2025 - Product Thumbnail Image

Immunoglobulin A IgA Vasculitis Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
From
Autoimmune Disease Testing Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Autoimmune Disease Testing Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 148 Pages
  • Global
From
From
Loading Indicator

Vasculitis is a group of disorders that involve inflammation of the blood vessels. It is a subset of Allergy and Immunology, which is the study of the body's immune system and its response to foreign substances. Symptoms of vasculitis can include fever, fatigue, joint pain, and skin rashes. Treatment typically involves medications such as corticosteroids, immunosuppressants, and biologics. Vasculitis is a rare condition, but it can have serious consequences if left untreated. Early diagnosis and treatment are important for managing the condition and preventing long-term complications. Research is ongoing to better understand the causes and develop new treatments. Companies in the Vasculitis market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more